{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:39:58Z","timestamp":1785465598962,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fondazione ART per la Ricerca sui Trapianti ART ONLUS"},{"name":"Fondazioni Aiuti per la Ricerca sulle Malattie Rare ARMR ONLUS"},{"name":"European Union Seventh Framework Programme FP7-EURenOmics"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1053\/j.ajkd.2015.06.032","type":"journal-article","created":{"date-parts":[[2015,9,27]],"date-time":"2015-09-27T08:54:41Z","timestamp":1443344081000},"page":"1067-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab"],"prefix":"10.1053","volume":"66","author":[{"given":"Carmine","family":"Pecoraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso Vincenzo Salvatore","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Rurali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Galbusera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Noris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.ajkd.2015.06.032_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2006-939763","article-title":"Thrombotic thrombocytopenic purpura\u2014then and now","volume":"32","author":"Galbusera","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"17","key":"10.1053\/j.ajkd.2015.06.032_bib2","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2015.06.032_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.blre.2014.01.003","article-title":"Diagnosis and management of complement mediated thrombotic microangiopathies","volume":"28","author":"Cataland","year":"2014","journal-title":"Blood Rev"},{"issue":"1","key":"10.1053\/j.ajkd.2015.06.032_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12185-009-0476-1","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"91","author":"Tsai","year":"2010","journal-title":"Int J Hematol"},{"issue":"20","key":"10.1053\/j.ajkd.2015.06.032_bib5","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.ajkd.2015.06.032_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.transci.2014.08.001","article-title":"Trends in the diagnosis and management of TTP:\u00a0European perspective","volume":"51","author":"Scully","year":"2014","journal-title":"Transfus Apher Sci"},{"issue":"23","key":"10.1053\/j.ajkd.2015.06.032_bib7","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1053\/j.ajkd.2015.06.032_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2015.06.032_bib9","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2215\/CJN.01640309","article-title":"Measurement and estimation of GFR in children and adolescents","volume":"4","author":"Schwartz","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2015.06.032_bib10","unstructured":"Agenzia Italiana del Farmaco. Pubblicazione schede di monitoraggio Registro SOLIRIS (SEUa). http:\/\/www.agenziafarmaco.gov.it\/it\/content\/pubblicazione-schede-di-monitoraggio-registro-soliris-seua-12012015. Accessed January 12, 2015."},{"issue":"11","key":"10.1053\/j.ajkd.2015.06.032_bib11","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.ajkd.2015.06.032_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2015.06.032_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1160\/TH10-06-0417","article-title":"Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies","volume":"105","author":"Palla","year":"2011","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1053\/j.ajkd.2015.06.032_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MOP.0b013e32835e7888","article-title":"Thrombotic thrombocytopenic purpura in children","volume":"25","author":"Loirat","year":"2013","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"10.1053\/j.ajkd.2015.06.032_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2012-01-403113","article-title":"Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura","volume":"120","author":"Lotta","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.ajkd.2015.06.032_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/bjh.12214","article-title":"Multiple in silico tools predict phenotypic manifestations in congenital thrombotic thrombocytopenic purpura","volume":"160","author":"Hing","year":"2013","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1053\/j.ajkd.2015.06.032_bib17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1538-7836.2012.04674.x","article-title":"Complement activation in thrombotic thrombocytopenic purpura","volume":"10","author":"Reti","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"10.1053\/j.ajkd.2015.06.032_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1160\/TH04-07-0450","article-title":"Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies","volume":"93","author":"Ruiz-Torres","year":"2005","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1053\/j.ajkd.2015.06.032_bib19","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.1301221","article-title":"Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy","volume":"191","author":"Tati","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1053\/j.ajkd.2015.06.032_bib20","doi-asserted-by":"crossref","first-page":"e59372","DOI":"10.1371\/journal.pone.0059372","article-title":"Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.ajkd.2015.06.032_bib21","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1182\/blood-2014-06-585430","article-title":"von Willebrand factor is a cofactor in complement regulation","volume":"125","author":"Feng","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.ajkd.2015.06.032_bib22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2141.2012.09084.x","article-title":"Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura","volume":"157","author":"Chapin","year":"2012","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.ajkd.2015.06.032_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/bjh.12387","article-title":"Use of eculizumab in the treatment of a case of refractory, ADAMTS13-deficient thrombotic thrombocytopenic purpura: additional data and clinical follow-up","volume":"162","author":"Tsai","year":"2013","journal-title":"Br J Haematol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615011269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615011269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:34:39Z","timestamp":1759458879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638615011269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0272638615011269"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.06.032","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}